Asha Therapeutics
San Francisco, United States· Est. 2019
Develops small molecule therapeutics targeting RNA for neurological and neuromuscular diseases.
Private Company
Total funding raised: $4.2M
About
Develops small molecule therapeutics targeting RNA for neurological and neuromuscular diseases.
Small Molecules
Funding History
1Total raised:$4.2M
Seed$4.2MJun 15, 2022